Workflow
Hill's Prescription Diet
icon
Search documents
Colgate-Palmolive Company (NYSE:CL) 2026 Earnings Call Presentation
2026-02-20 13:00
Consumer Analyst Group of New York Conference February 20, 2026 © 2026 Colgate-Palmolive Company TEAM NAME February 2026 Notice for Investor Presentation Please review the following presentation in conjunction with our fourth quarter and full year 2025 earnings press release, our fourth quarter and full year 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non- GAAP reconciliations, which are available in the Investor Center section of ...
Colgate-Palmolive(CL) - 2025 Q4 - Earnings Call Presentation
2026-01-30 13:30
4Q & Full Year 2025 EARNINGS PRESENTATION January 30, 2026 January 2026 Notice for Investor Presentation Please review the following fourth quarter and full year 2025 earnings presentation in conjunction with our fourth quarter and full year 2025 earnings press release, our fourth quarter and full year 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our web ...
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
Businesswire· 2025-11-18 14:30
Core Insights - Colgate-Palmolive will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 2, 2025 [1] - The company emphasizes its commitment to sustainability and community wellbeing, having reached approximately 2 billion children through its oral health program since 1991 [2] Financial Performance - For the third quarter of 2025, Colgate-Palmolive reported a 2.0% increase in net sales and a 0.4% increase in organic sales, despite a 0.8% negative impact from exiting the private label pet sales business [4] - GAAP EPS increased by 1% to $0.91, while Base Business EPS remained flat at $0.91 [4] - The GAAP gross profit margin decreased by 170 basis points to 59.4%, with the Base Business gross profit margin also decreasing by 190 basis points to 59.4% [4] Dividend Information - The Board of Directors declared a quarterly cash dividend of $0.52 per common share, payable on November 14, 2025, to shareholders of record on October 17, 2025 [6]
Procter & Gamble's Margins Stay Firm: Is Premiumization Paying Off?
ZACKS· 2025-08-07 16:25
Core Insights - Procter & Gamble Company's (PG) fourth-quarter fiscal 2025 results indicate steady margins despite global volatility, showcasing the effectiveness of its premiumization strategy [1][8] - The company achieved a 150-basis point expansion in core operating margin, driven by productivity improvements and disciplined reinvestment in innovation [1][8] - PG's core EPS grew by 6% year over year, reflecting its focus on product superiority and value across all tiers [1][2] Performance Drivers - PG's commitment to "irresistible superiority" across product, packaging, brand communication, retail execution, and holistic value has been a key driver of performance [2] - Successful product launches, such as Pampers in China and the SK-II LXP line, have gained significant market share by offering clear performance benefits [2] - The company's restructuring program aims to simplify its portfolio, optimize supply chains, and enhance organizational agility, creating room for further investment in its premium strategy [3] Competitive Landscape - In a challenging macroeconomic environment, peers like Colgate-Palmolive Company (CL) and Church & Dwight Co., Inc. (CHD) are also leveraging premiumization to maintain profitability [4] - Colgate maintained a gross margin of 60.1% in Q2 2025, benefiting from premium innovations and a favorable product mix [5] - Church & Dwight offset a 40-basis point decline in adjusted gross margin through productivity gains and strategic brand investments, reinforcing profitability [6] Valuation and Estimates - PG's shares have declined by 8.8% year to date, compared to a 5.6% dip in the industry [7] - The company trades at a forward price-to-earnings ratio of 21.73X, higher than the industry average of 19.46X [9] - The Zacks Consensus Estimate indicates year-over-year EPS growth of 2.3% for fiscal 2025 and 6.3% for fiscal 2026, although estimates have moved downward recently [10]
Momentum in Pet Business: A Catalyst for CL's Growth Phase?
ZACKS· 2025-06-11 18:55
Core Insights - Colgate-Palmolive Company's (CL) pet care business is a core strength and provides a competitive edge as demand for high-quality pet products and services rises in the growing pet industry [1][10] - The company is expanding its presence in the pet industry through comprehensive pet care solutions, particularly with its Hill's Pet Nutrition segment, which focuses on premium, veterinarian-led pet food [2][10] - Hill's Pet Nutrition competes globally and has delivered significant sales, contributing about 23% to overall quarterly sales in Q1 2025 [4] Company Strategy - Colgate's Hill's Pet Nutrition offers products under two labels: Hill's Science Diet for everyday nutritional needs and Hill's Prescription Diet for therapeutic pet foods [3] - The company plans to enter the fresh pet food market to further enhance its pet segment [2][10] - Colgate has agreed to acquire Care TopCo Pty Ltd, owner of the Prime100 pet food brand, to strengthen its position in the pet business [3] Competitive Landscape - Key competitors in the pet market include Tractor Supply Company (TSCO), Chewy, Inc. (CHWY), and Central Garden & Pet Company (CENT) [6] - TSCO adopts a multi-channel approach and has a loyalty program to enhance customer engagement, while Chewy focuses on e-commerce and technology upgrades to improve online sales [7][8] - CENT is recognized for its innovative solutions in the pet and garden spaces, offering a wide range of pet supplies [9][11] Financial Performance - In Q1 2025, Hill's Pet Nutrition segment achieved sales of $1.1 billion, with an expected year-over-year growth of 1.3% in 2025 [4] - Colgate's shares have gained 2.6% year-to-date, outperforming the industry's growth of 0.7% [12] - The forward price-to-earnings ratio for Colgate is 24.40X, compared to the industry average of 20.77X [13] Earnings Estimates - The Zacks Consensus Estimate for Colgate's EPS indicates year-over-year growth of 1.4% for 2025 and 7.3% for 2026, with stable estimates for 2025 and an upward revision for 2026 [14][15]
Colgate Stock Rises 7% in a Month: Buy or Wait for a Pullback?
ZACKS· 2025-03-04 16:35
Core Viewpoint - Colgate-Palmolive Company's stock performance indicates strong investor confidence, with a 7.2% increase in the past month, outperforming the industry and broader market indices [1][2]. Stock Performance - The company's shares have outperformed the industry growth of 4.8%, the Consumer Staples sector's decline of 1.9%, and the S&P 500's slight decline, showcasing resilience in a challenging market [1]. Growth Drivers - Key factors contributing to Colgate's stock momentum include effective pricing strategies, strong brand equity, innovation, and cost-saving initiatives [3][4]. - The company is focusing on premiumization in oral care and pet nutrition, alongside geographic diversification, which has positively impacted its sales [3]. Innovation and Strategy - Colgate has experienced strong business momentum, leading to higher organic sales driven by increased volume and improved pricing [4]. - The company is investing in digital, data, and analytics to enhance its competitive edge and profitability, with a strategy centered on core and premium innovations [5]. - Colgate's innovation strategy includes expanding into adjacent categories and enhancing its Oral Care portfolio with premium products [6]. Market Expansion - Beyond oral care, Colgate is growing its Naturals and Therapeutics divisions and has acquired Hello Products LLC, which supports its market share gains in specialty channels [7]. - The company has revamped its innovation model and invested in marketing to strengthen brand health and household penetration [7]. Future Outlook - Colgate is optimistic about its growth prospects, expecting consistent compounded earnings-per-share (EPS) growth in 2025 and beyond, with projected organic sales growth within the long-term target range of 3-5% [8][10]. - The company anticipates gross profit margin expansion and mid-single-digit growth in Base Business EPS for 2025 [10]. Challenges - Colgate faces challenges such as macroeconomic instability, inflationary pressures, and foreign currency headwinds, which have impacted profitability [12][13]. - In North America, net sales declined due to decreased pricing despite increased volume, while Latin America experienced unfavorable currency impacts [12][13]. Investment Perspective - Colgate's strong pricing strategies and innovation-driven approach position it well for long-term growth, making the stock attractive for long-term investors [14]. - However, ongoing macroeconomic challenges present near-term risks, leading to a recommendation for current investors to retain their positions while new investors may wait for a more favorable entry point [14].